APRE vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 16, 2026

APRE

36.8
AI Score
VS
CLYM Wins

CLYM

63.6
AI Score

Investment Advisor Scores

APRE

37score
Recommendation
SELL

CLYM

64score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric APRE CLYM Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -98.4% 0.0% CLYM
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 36.8/100 63.6/100 CLYM
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation SELL BUY CLYM

Relative Price Performance (Last 90 Days)

APRE 1M: -15.2% · 3M: -7.3% CLYM 1M: -27.3% · 3M: -17.6%

Current Technical Phase

APRE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 40.2 · Price: $0.70

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 30

RSI (14): 30.3 · Price: $10.94

Fundamentals Snapshot

Metric APRE CLYM
Market Cap — —
Forward P/E -2.0 -10.9
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -1.0% 0.0%
Gross Margin -1295.2% —
Operating Margin -2550.3% 0.0%
EPS -0.94 -0.79
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CLYM is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.